In a Congress that is often criticized for its inability to find common ground, today’s New York Times features an article which illustrates that bipartisanship is alive and well when it comes to medical implant device safety.

Titled “Bill Would Require More Monitoring of Implants,” the article describes efforts by key Senators to address what many believe to be a major flaw in the current implant approval process.

One of the sponsors of the legislation, Sen. Charles Grassley (R-Iowa), is also a supporter of structured settlements.  He was one of our industry’s featured speakers at the annual convention of the National Structured Settlements Trade Association in Washington, DC in 2009.

As part of their legislative effort, Sens. Grassley, Herb Kohl (D-Wisconsin) and Richard Blumenthal (D-Connecticut) also sent letters to several manufacturers requesting information on their tracking practices.  Johnson & Johnson, parent company of DePuy Orthopedics, maker of the now recalled ASR hip implants, was among the companies the Senators were seeking information from.

All patients affected by the recall of DePuy and other medical implant devices, are encouraged to visit our affiliated website, ASRHipSettlement, for information, including an informative video, on structured settlements as they apply to defective hip surgeries.

Our firm continues to follow this matter closely.